Wieder R - Search Results

1

Prescription coverage in indigent patients affects the use of long-acting opioids in the management of cancer pain.

Wieder R, Delarosa N, Bryan M, Hill AM, Amadio WJ. Wieder R, et al. Pain Med. 2014 Jan;15(1):42-51. doi: 10.1111/pme.12238. Epub 2013 Sep 23. Pain Med. 2014. PMID: 24106748 Free PMC article.

2

Phase I/II trial of accutane as a potentiator of carboplatin and paclitaxel in squamous cell carcinomas.

Wieder R, Pavlick AC, Bryan M, Hameed M, Baredes S, Pliner L, Saunders T, Korah R. Wieder R, et al. Am J Clin Oncol. 2002 Oct;25(5):447-50. doi: 10.1097/00000421-200210000-00004. Am J Clin Oncol. 2002. PMID: 12393981 Clinical Trial.

3

Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies.

Wieder R, Novick SC, Hollis BW, Bryan M, Chanel SM, Owusu K, Camastra D, Saunders T, Pliner L, Harrison J, Bonate P, Williams T, Soignet S. Wieder R, et al. Invest New Drugs. 2003 Nov;21(4):445-52. doi: 10.1023/a:1026203418976. Invest New Drugs. 2003. PMID: 14586212 Clinical Trial.

4

Influence of prescription benefits on reported pain in cancer patients.

Bryan M, De La Rosa N, Hill AM, Amadio WJ, Wieder R. Bryan M, et al. Among authors: wieder r. Pain Med. 2008 Nov;9(8):1148-57. doi: 10.1111/j.1526-4637.2008.00427.x. Epub 2008 Mar 11. Pain Med. 2008. PMID: 18346057

5

A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer.

Bryan M, Pulte ED, Toomey KC, Pliner L, Pavlick AC, Saunders T, Wieder R. Bryan M, et al. Among authors: wieder r. Invest New Drugs. 2011 Dec;29(6):1482-7. doi: 10.1007/s10637-010-9478-3. Epub 2010 Jul 2. Invest New Drugs. 2011. PMID: 20596747 Clinical Trial.

6

Establishing a minority-based community clinical oncology program: the University of Medicine and Dentistry of New Jersey, New Jersey Medical School-university Hospital Cancer Center experience.

Wieder R, Teal R, Saunders T, Weiner BJ. Wieder R, et al. J Oncol Pract. 2013 Mar;9(2):e48-54. doi: 10.1200/JOP.2012.000648. J Oncol Pract. 2013. PMID: 23814524 Free PMC article.

7

Improving cancer patient emergency room utilization: A New Jersey state assessment.

Scholer AJ, Mahmoud OM, Ghosh D, Schwartzman J, Farooq M, Cabrera J, Wieder R, Adam NR, Chokshi RJ. Scholer AJ, et al. Among authors: wieder r. Cancer Epidemiol. 2017 Dec;51:15-22. doi: 10.1016/j.canep.2017.09.006. Epub 2017 Oct 4. Cancer Epidemiol. 2017. PMID: 28987963

8

African American Race is an Independent Risk Factor in Survival from Initially Diagnosed Localized Breast Cancer.

Wieder R, Shafiq B, Adam N. Wieder R, et al. J Cancer. 2016 Jul 18;7(12):1587-1598. doi: 10.7150/jca.16012. eCollection 2016. J Cancer. 2016. PMID: 27698895 Free PMC article.

9

Greater Survival Improvement in African American vs. Caucasian Women with Hormone Negative Breast Cancer.

Wieder R, Shafiq B, Adam N. Wieder R, et al. J Cancer. 2020 Feb 21;11(10):2808-2820. doi: 10.7150/jca.39091. eCollection 2020. J Cancer. 2020. PMID: 32226499 Free PMC article.

10

Drug repositioning for cancer in the era of AI, big omics, and real-world data.

Wieder R, Adam N. Wieder R, et al. Crit Rev Oncol Hematol. 2022 Jul;175:103730. doi: 10.1016/j.critrevonc.2022.103730. Epub 2022 May 30. Crit Rev Oncol Hematol. 2022. PMID: 35654244 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters